Quarterly Call Option Transactions in Crispr Therapeutics Ag (CRSP)
This table provides information about the institutional ownership of Crispr Therapeutics Ag (CRSP) during . The information is specifically focused on institutions that hold call options of CRISPR Therapeutics AG.
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 65,600 | 119,933 | 185,533 | 506,200 | 118,100 | 624,300 | -438,767 | |
| Q4 2021 | 388,700 | 100,800 | 489,500 | 429,100 | 4,000 | 433,100 | 56,400 | |
| Q1 2022 | 453,000 | 88,000 | 541,000 | 233,400 | 17,700 | 251,100 | 289,900 | |
| Q2 2022 | 429,000 | 10,000 | 439,000 | 56,200 | 25,200 | 81,400 | 357,600 | |
| Q3 2022 | 302,600 | 121,100 | 423,700 | 29,500 | 0 | 29,500 | 394,200 | |
| Q4 2022 | 107,400 | 149,700 | 257,100 | 821,600 | 0 | 821,600 | -564,500 | |
| Q1 2023 | 72,600 | 58,600 | 131,200 | 646,500 | 0 | 646,500 | -515,300 | |
| Q2 2023 | 318,100 | 468,026 | 786,126 | 204,000 | 0 | 204,000 | 582,126 | |
| Q3 2023 | 58,500 | 48,500 | 107,000 | 390,487 | 0 | 390,487 | -283,487 | |
| Q4 2023 | 1,675,281 | 200,300 | 1,875,581 | 8,900 | 0 | 8,900 | 1,866,681 | |
| Q1 2024 | 525,200 | 104,600 | 629,800 | 783,736 | 0 | 783,736 | -153,936 | |
| Q2 2024 | 102,600 | 44,390 | 146,990 | 1,206,985 | 0 | 1,206,985 | -1,059,995 | |
| Q3 2024 | 0 | 10,612 | 10,612 | — | 10,612 | |||